Treatment Sequence of Aromatase Inhibitors and Radiotherapy and Long-term Outcomes of Breast Cancer Patients
- MAKOTO ISHITOBI1⇑,
- MIZUHO SHIBA1,
- TAKAHIRO NAKAYAMA1,
- KAZUYOSHI MOTOMURA1,
- HIROKI KOYAMA1,
- KINJI NISHIYAMA2 and
- YASUHIRO TAMAKI1
- 1Department of Breast and Endocrine Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
- 2Department of Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
- Correspondence to: Makoto Ishitobi, MD, Department of Breast and Endocrine Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan. Tel: +81 669721181, Fax: +81 669818055, e-mail: isitobi-ma{at}mc.pref.osaka.jp
-
Figure 1.Disease-free survival curves according to treatment sequence.
- Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
